Coronavirus Disease 2019 (COVID-19) Associated Hemolytic Uremic Syndrome in a Toddler
Coronavirus disease 2019 (COVID-19) is a heterogenous, predominantly pulmonary disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has resulted in catastrophic illness around the world. Thrombotic microangiopathy (TMA) is a triad of hemolytic anemia, thrombocytopenia,...
Saved in:
Main Authors: | Kristie Searcy, Apoorva Jagadish, Patricia Pichilingue-Reto, Radhakrishna Baliga |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2022/3811170 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical hemolytic uremic syndrome with a C3 variant following COVID-19: a case report
by: Masato Ando, et al.
Published: (2025-01-01) -
Anti-Factor H Antibodies in Egyptian Children with Hemolytic Uremic Syndrome
by: Shereen Shawky, et al.
Published: (2021-01-01) -
Hemolytic Uremic Syndrome Associated with Pneumococcal Pneumonia. A Case Report
by: Ariel Efrén Uriarte Méndez, et al.
Published: (2013-06-01) -
Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic Syndrome
by: Han-Mou Tsai, et al.
Published: (2014-01-01) -
Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
by: Xinlei Sun, et al.
Published: (2025-01-01)